Pascale Foundation

Breast cancer: how the Boom project measures value to improve the care pathway

Plans are in place to develop a multidimensional dashboard capable of integrating clinical outcomes, organisational aspects, resources and patients’ experiences

Computer Screen in Hospital Radiology Room: Beautiful Multiethnic Adult Woman Standing Topless Undergoing Mammography Screening Procedure. Screen Showing the Mammogram Scans of Dense Breast Tissues. Gorodenkoff - stock.adobe.com

3' min read

Translated by AI
Versione italiana

3' min read

Translated by AI
Versione italiana

When discussing the quality of cancer care, the first indicators that spring to mind are inevitably the clinical ones: response to treatment, survival rates and the safety of care. But to truly understand the value of a care pathway, we must also look beyond these. Organisation, a multidisciplinary approach, continuity of care and the ability to respond to patients’ needs are equally important aspects.

It is from this vision that BOOM – Breast Outputs and Outcomes Monitoring – was conceived, a project aimed at developing a multidimensional system for measuring and monitoring the diagnostic and therapeutic pathway for breast cancer.

Loading...

The project owes its clinical substance above all to the experience gained at the IRCCS National Cancer Institute “Fondazione G. Pascale” in Naples, through the work of the team led by Prof. Michelino De Laurentiis, together with Dr Roberta Caputo, who have been committed for years to the treatment of breast cancer and, in particular, to the care of patients with metastatic disease. Joining them is the VIMASS LAB at Parthenope University in Naples, working together to transform clinical experience into new tools for measuring and improving care pathways.

A care pathway designed for patients with metastatic disease

At the Pascale Hospital, the focus on patients with metastatic cancer has led to the development of a specific care pathway, through a Multidisciplinary Oncology Group (GOM) dedicated to metastatic disease, which, according to the clinical team, represents a unique initiative within the Italian healthcare system.

A decision born of a practical need. There are many patients with metastatic breast cancer, and they may live with the disease for a long time. Their journey cannot therefore be viewed solely in terms of a single course of treatment, but requires continuity, a multidisciplinary approach and a constant ability to adapt care to the needs that arise over time.

A project that began a long time ago

It is on this conviction that the Pascale team has built its work over the years.

“We have firmly believed in the need to create a care pathway specifically designed for patients with metastatic disease, and we have been working towards this for years. There are many such patients, and their needs are complex, requiring a structured and continuous approach to their care. We want to offer them specialised care, tailored to their needs, and to be actively involved throughout their journey with the disease,” emphasises Prof. De Laurentiis.

This view is shared by Dr Roberta Caputo, who draws attention to the need to consider the individual beyond the scope of a single clinical procedure.

“Caring for a patient with metastatic disease means supporting her over time. We cannot limit ourselves to the treatment phase alone: we must listen to her needs, understand how they change at different stages of the disease, and develop responses that are truly appropriate. Our commitment stems precisely from our desire to be there for these women and to offer them a dedicated care pathway,” explains Caputo.

The results presented in 2027

It is precisely from the experience gained on a daily basis in the care of patients that BOOM intends to begin, transforming clinical practice into measurable data that can be used to improve care. The 12-month project involves the development of a multidimensional dashboard dedicated to the breast cancer pathway, capable of integrating clinical outcomes, organisational aspects, resources and patients’ experiences. In this context, the Pascale Multidisciplinary Team (GOM) specialising in metastatic disease represents a particularly significant example. The collaboration also involves the CROB in Rionero in Vulture and the IRCCS ‘Giovanni Paolo II’ Cancer Institute in Bari. The BOOM project, the results of which will be presented in spring 2027, is being carried out with an unrestricted grant from Novartis.

Loading...

*Full Professor of Management, University of Naples Parthenope

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti